PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:03 AM ET

Sponsor Check › Person

EW
No photo found yet (own website and image search run after this page is viewed)

Edward Weinstein

Named as an officer, director or promoter on SEC Form D filings · MO · Jul 31, 2017 → Nov 21, 2024

3deals (issuers)
$8.34Mreported sold
28investors
5Form D filings
2017–2024years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:39 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Edward Weinstein is listed as an executive officer and director on 5 SEC Form D filings by 3 issuers between Jul 2017 and Nov 2024: Panome Bio Inc. (Saint Louis, MO — biotechnology — 2023–2024; $6M reported sold to 6 investors), Canopy Biosciences, LLC (Saint Louis, MO — biotechnology — 2017–2018; $2.08M reported sold to 16 investors) and Inflection Point Genetics Inc. (St. Louis, MO — biotechnology — 2022; $265K reported sold to 6 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 7 years. Across those companies the filings report $8.34M sold in total.

Listed alongside David Smoller (4 shared filings), CRYSTAL WINKELER (2 shared filings), Charles Bolten (2 shared filings), DAVID KINGSLEY (2 shared filings), Deval Lashkari (2 shared filings) and 3 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Edward. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 4 bankruptcy cases matching the name listed in Key records below.

What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 5 public filings for Edward Weinstein and found 3 differences, 1 worth asking the sponsor about: Form D filed 279 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Edward Weinstein has not run yet — it is joining a line of 5,196 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:39 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Edward Weinstein..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

4 cases: 4 closed (disposition not in docket feed)

Edward T. Weinstein and Daryl A. Weinstein closed
United States Bankruptcy Court, D. New Jersey · No. 19-11748 · Filed Jan 28, 2019 · Closed Jul 6, 2022
Role of Edward T. Weinstein and Daryl A. Weinstein: Debtor · Outcome: Case closed 2022-07-06 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 4 federal dockets); court in NJ (not a filing state)
Edward Weinstein and Vera Weinstein closed
United States Bankruptcy Court, D. New Jersey · No. 11-34182 · Filed Aug 13, 2011 · Closed Mar 22, 2017
Role of Edward Weinstein and Vera Weinstein: Debtor · Outcome: Case closed 2017-03-22 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 4 federal dockets); court in NJ (not a filing state)
Edward R. Weinstein and Natalie Weinstein closed
United States Bankruptcy Court, D. New Jersey · No. 94-34657 · Filed Jul 21, 1994 · Closed Mar 15, 1995
Role of Edward R. Weinstein and Natalie Weinstein: Debtor · Outcome: Case closed 1995-03-15 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 4 federal dockets); court in NJ (not a filing state)
Edward Weinstein closed
United States Bankruptcy Court, E.D. Pennsylvania · No. 93-15816 · Filed Oct 4, 1993 · Closed Apr 22, 1994
Role of Edward Weinstein: Debtor · Outcome: Case closed 1994-04-22 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 4 federal dockets); court in PA (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:39 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

3 differences found between the filings for Edward Weinstein — 1 worth asking about (compared 5 filings on Oct 24, 2026)

Worth asking · Oct 25, 2016 – Jul 31, 2017

Form D filed 279 days after the first sale — Canopy Biosciences, LLC

The filing says the first sale was Oct 25, 2016. The Form D was filed Jul 31, 2017 — 279 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 264 days past that.

What this means The notice went in months after money was taken in. Late notices are common and carry no penalty by themselves, but it is fair to ask the sponsor why the paperwork lagged.

Sources
Note · Oct 24, 2022 – Nov 8, 2022

No amendment in the last 12 months on an offering that may still be open — Inflection Point Genetics Inc. (latest filing Nov 8, 2022)

The latest filing for this offering is dated Nov 8, 2022 (first sale Oct 24, 2022). It reports $265,005 sold of $1,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Dec 20, 2017 – Jan 3, 2018

No amendment in the last 12 months on an offering that may still be open — Canopy Biosciences, LLC (latest filing Jan 3, 2018)

The latest filing for this offering is dated Jan 3, 2018 (first sale Dec 20, 2017). It reports $2,075,000 sold of $3,400,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 5 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Nov 21, 2024 D
Panome Bio Inc.
File 021-530044
$0$0$0
A portion of the proceeds will be used for general working capital, which may include salary payments to executive officers and directors. An estimate of such amount is unknown at this time.
None listed on this filingEDGAR ↗
Feb 24, 2023 D
Panome Bio Inc.
File 021-474235
$0$0$0
A portion of the proceeds will be used for general working capital, which may include salary payments to executive officers and directors. An estimate of such amount is unknown at this time.
None listed on this filingEDGAR ↗
Nov 8, 2022 D
Inflection Point Genetics Inc.
File 021-464185
$0$0$0
A portion of the proceeds will be used for general working capital, which may include salary payments to executive officers and directors. An estimate of such amount is unknown at this time.
None listed on this filingEDGAR ↗
Jan 3, 2018 D
Canopy Biosciences, LLC
File 021-302234
$0$0$0
A portion of the gross proceeds will be used for general working capital, which may include salary payments to executive officers and managers. An estimate of such amount is unknown at this time.
None listed on this filingEDGAR ↗
Jul 31, 2017 D
Canopy Biosciences, LLC
File 021-291783
$0$0$0
A portion of the gross proceeds will be used for general working capital, which may include salary payments to executive officers and managers. An estimate of such amount is unknown at this time.
None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named Edward Weinstein on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

Panome Bio Inc.

Saint Louis, MO · Feb 24, 2023 → Nov 21, 2024 · 2 filings
  • Nov 21, 2024 · D · $6,000,000 sold of $6,000,000 · 6 investors · min. $25,000 · role: Executive Officer, Director EDGAR ↗
  • Feb 24, 2023 · D · $5,973,835 sold of $5,973,835 · 6 investors · min. $20,000 · role: Executive Officer, Director EDGAR ↗

Raised $6M from 6 investors (100% of the $6M target) as of the latest filing. Edward is listed as executive officer, director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Inflection Point Genetics Inc.

St. Louis, MO · Nov 8, 2022
  • Nov 8, 2022 · D · $265,005 sold of $1,000,000 · 6 investors · min. $15,000 · role: Executive Officer, Director EDGAR ↗

Raised $265K from 6 investors (27% of the $1M target) as of the latest filing. Edward is listed as executive officer, director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Canopy Biosciences, LLC

Saint Louis, MO · Jul 31, 2017 → Jan 3, 2018 · 2 filings
  • Jan 3, 2018 · D · $2,075,000 sold of $3,400,000 · 16 investors · min. $20,000 · role: Executive Officer, Director (PRESIDENT, CHIEF EXECUTIVE OFFICER AND MANAGER) EDGAR ↗
  • Jul 31, 2017 · D · $1,125,000 sold of $1,125,000 · 15 investors · min. $20,000 · role: Executive Officer, Director (President, Chief Executive Officer and Manager) EDGAR ↗

Raised $2.08M from 16 investors (61% of the $3.4M target) as of the latest filing. Edward is listed as executive officer, director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Edward 8

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

David Smoller

Director · 4 shared filings (2 issuers) · also on 8 other issuers

David Smoller is on 10 issuers in total — a repeat sponsor. Their page lists every one.

DL
No photo found yet (own website and image search run after this page is viewed)
Person

Deval Lashkari

Director · 2 shared filings (1 issuer) · also on 8 other issuers

Deval Lashkari is on 9 issuers in total — a repeat sponsor. Their page lists every one.

CB
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Bolten

Director · 2 shared filings (1 issuer) · also on 13 other issuers

Charles Bolten is on 14 issuers in total — a repeat sponsor. Their page lists every one.

CW
No photo found yet (own website and image search run after this page is viewed)
Person

CRYSTAL WINKELER

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Edward Weinstein. Their page shows their other deals.

DK
No photo found yet (own website and image search run after this page is viewed)
Person

DAVID KINGSLEY

Director · 2 shared filings (1 issuer)

Listed on the same filings as Edward Weinstein. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Rob Capone

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Edward Weinstein. Their page shows their other deals.

TC
No photo found yet (own website and image search run after this page is viewed)
Person

Tom Cohen

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Edward Weinstein. Their page shows their other deals.

AH
No photo found yet (own website and image search run after this page is viewed)
Person

Alexander Herzick

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Edward Weinstein. Their page shows their other deals.

The team behind the deals

Registrations and other filings

Adviser registration (Form ADV)

None of the 3 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Edward Weinstein by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 3 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Edward Weinstein is listed on: none on file. No website or social profile named in Panome Bio Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #85,742 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Saint Louis, MO). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Edward Weinstein appears on a new Form D, or when a court case or SEC action is matched to them. See plans →